Insider · CIK 0001354434

Renaud Ronald C JR

Reports to the SEC for 10 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001354434

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	KLRAKailera Therapeutics, Inc.M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	+38.1K sh	$5.25	+$200K	38,094
2026-06-09	KLRAKailera Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, CEO & President	MExercise/Conversion	−38.1K sh	—	—	817,826
2026-06-09	UPBUpstream Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.1K sh	—	—	17,096
2026-04-16	KLRAKailera Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, CEO & President	AAward	+300K sh	—	—	300,000
2026-04-16	KLRAKailera Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, CEO & President	AAward	+300K sh	—	—	300,000
2025-06-10	UPBUpstream Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.1K sh	—	—	17,096
2024-10-10	UPBUpstream Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.1K sh	—	—	17,096
2024-08-01	Cerevel Therapeutics Holdings, Inc.D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−160K sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−83.9K sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−216K sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsD Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−284K sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.Performance-based Restricted Stock UnitsD Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−321K sh	—	—	0
2024-01-19	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsA Award	Director, President & CEO	AAward	+284K sh	—	—	284,023
2023-12-19	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+160K sh	—	—	160,452
2023-12-19	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−160K sh	—	—	0
2023-08-03	Cerevel Therapeutics Holdings, Inc.P Purchase	Director, President & CEO	PPurchase	+83.9K sh	$23.96	+$2.01M	83,857
2023-06-12	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+216K sh	—	—	215,749
2023-06-12	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsA Award	Director, President & CEO	AAward	+160K sh	—	—	160,452
2023-06-12	Cerevel Therapeutics Holdings, Inc.Performance-based Restricted Stock UnitsA Award	Director, President & CEO	AAward	+160K sh	—	—	160,371
2022-06-23	ATRAAtara Biotherapeutics, Inc.A Award	Director	AAward	+20.5K sh	—	—	31,500
2022-06-23	ATRAAtara Biotherapeutics, Inc. · Non-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+31.5K sh	—	—	31,500
2022-06-09	IMAImageneBio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13.4K sh	—	—	13,419
2021-12-21	IMAImageneBio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13.4K sh	—	—	13,419
2021-09-14	Translate Bio, Inc.S Sale	Director, Chief Executive Officer	SSale	−503K sh	$38.00	−$19.1M	0
2021-09-14	Translate Bio, Inc.S Sale	Director, Chief Executive Officer	SSale	−410K sh	$38.00	−$15.6M	0
2021-09-14	Translate Bio, Inc.S Sale	Director, Chief Executive Officer	SSale	−40.9K sh	$38.00	−$1.55M	0
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Director, Chief Executive Officer	SSale	−500K sh	—	—	0
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Director, Chief Executive Officer	SSale	−525K sh	—	—	0
2021-09-14	Translate Bio, Inc.Stcok Option (right to buy)S Sale	Director, Chief Executive Officer	SSale	−325K sh	—	—	0
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Director, Chief Executive Officer	SSale	−1.07M sh	—	—	0
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Director, Chief Executive Officer	SSale	−90K sh	—	—	0
2021-06-08	ATRAAtara Biotherapeutics, Inc.A Award	Director	AAward	+11K sh	—	—	11,000
2021-06-08	ATRAAtara Biotherapeutics, Inc. · Non-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2021-04-07	Translate Bio, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+9,026 sh	$7.39	+$66.7K	503,321
2021-04-07	Translate Bio, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−9,026 sh	—	—	1,071,009
2021-04-07	Translate Bio, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+9,026 sh	$7.39	+$66.7K	503,231
2021-04-07	Translate Bio, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−9,026 sh	—	—	1,071,009
2021-03-09	Translate Bio, Inc.Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+325K sh	—	—	325,000
2021-01-14	Translate Bio, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+5,638 sh	$7.39	+$41.7K	494,204
2021-01-14	Translate Bio, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1 sh	$8.34	+$8.34	494,205
2021-01-14	Translate Bio, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−5,638 sh	—	—	1,080,035
2021-01-14	Translate Bio, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1 sh	—	—	89,996
2020-11-16	Translate Bio, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+53K sh	$7.39	+$392K	488,563
2020-11-16	Translate Bio, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+3 sh	$8.34	+$25.02	488,566
2020-11-16	Translate Bio, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−53K sh	—	—	1,085,673
2020-11-16	Translate Bio, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−3 sh	—	—	89,997
2020-04-29	ATRAAtara Biotherapeutics, Inc. · Non-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+71.5K sh	—	—	71,500
2020-03-03	Translate Bio, Inc.Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+525K sh	—	—	525,000
2019-06-20	CHIMERIX INCStock Option (Right to Buy)A Award	Director	AAward	+21K sh	—	—	21,000
2019-03-08	Translate Bio, Inc.Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+500K sh	—	—	500,000

Recent filings

Accepted (ET)
Jun 114
Renaud Ronald C JR0001193125-26-268168
SEC(opens sec.gov)
Jun 114
Renaud Ronald C JR0001193125-26-267493
SEC(opens sec.gov)
Apr 204
Renaud Ronald C JR0001193125-26-164299
SEC(opens sec.gov)
Jun 124
Renaud Ronald C JR0000950170-25-085373
SEC(opens sec.gov)
Oct 154
Renaud Ronald C JR0000950170-24-114687
SEC(opens sec.gov)
Aug 54
Renaud Ronald C JR0000950170-24-090851
SEC(opens sec.gov)
Jan 234
Renaud Ronald C JR0000950170-24-006667
SEC(opens sec.gov)
Dec 214
Renaud Ronald C JR0000950170-23-072374
SEC(opens sec.gov)
Aug 74
Renaud Ronald C JR0000950170-23-039169
SEC(opens sec.gov)
Jun 144
Renaud Ronald C JR0000899243-23-015539
SEC(opens sec.gov)
Jun 274
Renaud Ronald C JR0001140361-22-024159
SEC(opens sec.gov)

Companies

Address

UPSTREAM BIO, INC. 890 WINTER STREET, SUITE 200

WALTHAM, MA, 02451